Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Myelodysplastic syndrome is a myeloproliferative disorder that may be caused by somatic mutations of the ASXL1 gene.
| 1. |
Hahn CN et al. (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. 
|
| 2. |
Ortmann CA et al. (2015) Effect of mutation order on myeloproliferative neoplasms.
|
| 3. |
Walter MJ et al. (2011) Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
|
| 4. |
Delhommeau F et al. (2009) Mutation in TET2 in myeloid cancers.
|
| 5. |
Papaemmanuil E et al. (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
|
| 6. |
OMIM.ORG article Omim 614286
|
| 7. |
Orphanet article Orphanet ID 52688
|
| 8. |
Wikipedia article Wikipedia EN (Myelodysplastic_syndrome)
|
 |
Copyright © 2005-2025 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |
